| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bbf89c005f900e2ec05c2c6c5587976
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_34ad3aad0011bf79b276b657f5d302e5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-56 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6893 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2005-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_534d02a59cdd2741f628e4aa186319f5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_903ae8764b7a6fe02d08e1694c1f9bec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6282e4a5f5c3b2f97b0aa7cd627fdec8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_52618c066fb7923e119dd4d7c7fa6034
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_31490cd7fa4924fa58e67a7225586fc4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0afe332b14b99ae93729d95b5073634
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eb8ebcdce972cec83b1f72b94f3321e8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_731ad27583529a139f6458f75d1b44e5 |
| publicationDate |
2012-09-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2386966-T3 |
| titleOfInvention |
Method to diagnose infectious diseases by measuring the level of soluble TREM-1 in a sample |
| abstract |
A method for diagnosing a disease of bacterial or fungal origin in a subject, wherein said disease is pneumonia or septicemia, said method comprising the step of measuring the level of sTREM-1 (soluble form of the trigger receptor expressed in myeloid-1 cells) in a biological sample of body fluid obtained from said subject, compare the measured level of sTREM-1 in the sample with an average level in a control population that does not suffer from such a bacterial or fungal disease, with high levels of sTREM-1 being indicative compared to said control of the presence or extent of said disease of bacterial or fungal origin in the patient, wherein said step of measuring the level of sTREM-1 in turn comprises the steps of: (a) contacting said biological sample with a antibody capable of specifically binding asTREM-1; and (b) detect the level of sTREM-1 present in the sample by observing the level of binding between said antibody and sTREM-1. |
| priorityDate |
2004-01-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |